According to FibroGen's latest financial reports the company's current EPS (TTM) is -$5.75. In 2022 the company made an earnings per share (EPS) of -$5.33 a decrease over its 2021 EPS that were of -$5.33.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$5.58 | 4.83% |
2022 | -$5.33 | -0% |
2021 | -$5.33 | 48.11% |
2020 | -$3.60 | 140.91% |
2019 | -$1.49 | -14.56% |
2018 | -$1.75 | -32.68% |
2017 | -$2.60 | 64.52% |
2016 | -$1.58 | -34.51% |
2015 | -$2.41 | -6.98% |
2014 | -$2.59 |